S33 The National Burden of Advanced Chronic Kidney Disease on Hospital Outcomes in Acute Pancreatitis

Introduction: Acute pancreatitis (AP) is a common gastrointestinal condition often requiring hospitalization, with outcomes influenced by numerous comorbidities. Among these, chronic kidney disease (CKD), particularly in its advanced stages, may significantly complicate the clinical course due to fluid imbalance and impaired metabolic regulation. Despite this potential interaction, the impact of advanced CKD on inpatients with AP remains underexplored. This study aims to evaluate the impact of advanced CKD on key inpatient outcomes in patients with AP. Methods: A retrospective cohort study was conducted using the Nationwide Inpatient Sample from 2016 to 2021 to identify adult patients admitted for AP. Patients were stratified into advanced CKD (eGFR <15 mL/min) and non-advanced CKD (eGFR ≥15 mL/min). Multivariable logistic regression was used to assess the association between advanced CKD and in-hospital mortality, while linear regression analyzed variations in total hospital charges, costs, and length of stay (LOS). The models were adjusted for patient demographics (age, gender, race, residence, median household income), Charlson Comorbidity Index, and hospital characteristics (region, teaching status, bed size). Results: Among 1,643,153.9 acute pancreatitis hospitalizations, 31,040 (1.9%) had advanced CKD. Compared to non-advanced CKD patients, advanced CKD patients were significantly more likely to be Black (42.7% vs 16.2%), have Medicaid (69.1% vs 28.7%), with higher Charlson score (84.3% vs 15.0%), and reside in lower-income quartiles (42.1% vs 31.7%). After multivariable adjustment, advanced CKD was independently associated with increased odds of in-hospital mortality (adjusted odds ratio: 1.37, 95% CI 1.09-1.71, P < 0.01). Furthermore, advanced CKD was associated with significantly higher mean total hospital charges (adjusted coefficient $16,878.29, 95% CI $12,340.69-$21,415.89, P < 0.01), and longer LOS (0.78 days, 0.51-1.04, P < 0.01). Conclusion: Our study identified that increased inpatient mortality and total hospital charges in acute pancreatitis are associated with advanced CKD status. These findings inform the significance of a multidisciplinary approach with nephrologists in these high-risk patients with AP to improve clinical outcomes.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001126592.13062.ab
Primary Topic
Pancreatitis Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S33 The National Burden of Advanced Chronic Kidney Disease on Hospital Outcomes in Acute Pancreatitis

Bright Nwatamole, Omar Oudit, Abdelaziz Mohamed, Mohammad K. Hassan et al.
The American Journal of Gastroenterology
Pancreatitis Pathology and Treatment
article

S33 The National Burden of Advanced Chronic Kidney Disease on Hospital Outcomes in Acute Pancreatitis

Bright Nwatamole, Omar Oudit, Abdelaziz Mohamed, Mohammad K. Hassan, Adedeji Adenusi, Samuel Sule-Saa, Mark Anthony Ntow, Rebecca Kotei
article en

Abstract

Introduction: Acute pancreatitis (AP) is a common gastrointestinal condition often requiring hospitalization, with outcomes influenced by numerous comorbidities. Among these, chronic kidney disease (CKD), particularly in its advanced stages, may significantly complicate the clinical course due to fluid imbalance and impaired metabolic regulation. Despite this potential interaction, the impact of advanced CKD on inpatients with AP remains underexplored. This study aims to evaluate the impact of advanced CKD on key inpatient outcomes in patients with AP. Methods: A retrospective cohort study was conducted using the Nationwide Inpatient Sample from 2016 to 2021 to identify adult patients admitted for AP. Patients were stratified into advanced CKD (eGFR <15 mL/min) and non-advanced CKD (eGFR ≥15 mL/min). Multivariable logistic regression was used to assess the association between advanced CKD and in-hospital mortality, while linear regression analyzed variations in total hospital charges, costs, and length of stay (LOS). The models were adjusted for patient demographics (age, gender, race, residence, median household income), Charlson Comorbidity Index, and hospital characteristics (region, teaching status, bed size). Results: Among 1,643,153.9 acute pancreatitis hospitalizations, 31,040 (1.9%) had advanced CKD. Compared to non-advanced CKD patients, advanced CKD patients were significantly more likely to be Black (42.7% vs 16.2%), have Medicaid (69.1% vs 28.7%), with higher Charlson score (84.3% vs 15.0%), and reside in lower-income quartiles (42.1% vs 31.7%). After multivariable adjustment, advanced CKD was independently associated with increased odds of in-hospital mortality (adjusted odds ratio: 1.37, 95% CI 1.09-1.71, P < 0.01). Furthermore, advanced CKD was associated with significantly higher mean total hospital charges (adjusted coefficient $16,878.29, 95% CI $12,340.69-$21,415.89, P < 0.01), and longer LOS (0.78 days, 0.51-1.04, P < 0.01). Conclusion: Our study identified that increased inpatient mortality and total hospital charges in acute pancreatitis are associated with advanced CKD status. These findings inform the significance of a multidisciplinary approach with nephrologists in these high-risk patients with AP to improve clinical outcomes.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 52%
Pancreatitis Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.